Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

TSE:ZUH

BMO EqWt US HthCare Hedged CAD (ZUH.TO)

68.82
+0.66 (0.97%)
as of Jun 11, 2026, 5:41:22 pm Market Open.
76 watching
0
Investor Insights
star iconJun 11, 2026, 12:00 am

This summary was created by AI, based on 1 opinions in the last 12 months.

The BMO EqWt US HthCare Hedged CAD (ZUH-T) is highly regarded due to its equal-weight strategy, which effectively mitigates concentration risks associated with mega-pharmaceutical firms. Operating within the pharmaceutical, biotech, and healthcare services sectors, it is characterized by lower volatility, making it a viable diversifier against the concentrated leadership seen in current market indices. The defensive growth nature of this sector is particularly appealing as it tends to exhibit steady demand, reinforced by companies maintaining strong balance sheets and low sensitivity to economic fluctuations. Furthermore, the anticipated surge in healthcare innovation powered by AI presents a substantial growth opportunity, positioning this investment favorably. It is important to note that while the expert manages exposure for clients through the futures market and does not directly own the ETF, he emphasizes the strategic benefits of this approach.

consensus icon
Consensus
Positive
valuation icon
Valuation
Fair Value
review icon
Similar
Vanguard, VHT
TOP PICK

Equal weight avoids concentration in mega-pharma. Pharma, biotech, healthcare services. Lower volatility sector, so it helps diversify against the narrow leadership in the indexes right now. Defensive growth, steady demand in the area, strong balance sheets, low economic sensitivity. Good valuations.

Kicker is lots of healthcare innovation coming due to AI, and this will be a huge benefit.

Disclosure:  Owns this for clients via the futures market. Though he may own similar exposure at times, he doesn't own the individual ETF. His team creates the exposure in a different way.

BUY

MER is 0.72%. Easy to understand. Not a market cap weighted ETF

BUY
Well diversified health care ETF (hospitals, surgical implements etc.) Matter of when to buy is the question.
PAST TOP PICK
(A Top Pick Nov 09/20, Up 21%) He likes it, likes this niche though ZUH is diversified in hospital care and big pharma.
COMMENT

They use a covered call strategy to enhance the yield. Those who want exposure to healthcare space but want higher yield, it is a good option. If yield is not a concern for you, you're better off with ZUH.

TOP PICK
A demographic play. It is not totally pharma. It is equipment and hospitals, too. It has done well.
BUY

Billy Kawasaki’s Insights - Picks from 5i Research. Healthcare is likely to be a strong performer in the next five years. Subsectors like medical devices, telemedicine and therapeutics should lead. A good ETF for US exposure. Unlock Premium - Try 5i Free

COMMENT
These are some of the best ETFs for playing healthcare depending on what strategy you like. These cover global, covered call, yield focused, or actively managed ETFs in the market. The sector is a little overvalued right now so you might want to wait for a pullback. Longterm outlook is favourable.
WAIT
Long-term, as a theme, you have to like healthcare. The aging demographic and bio-technology will be important factors. Short-term, the bio-tech stocks are over-bought. There is speculation in vaccines. However, long term it will be positive.
HOLD

He does not own this one. They have an effective covered call strategy and has no issues with the fund at all. He prefers ZUH, where it is not impeded with calls being written.

BUY

Healthcare ETF? He likes ZUH as it includes pharma, hospitals and other medical services. It is hedged to the Canadian dollar.

PAST TOP PICK
(A Top Pick Apr 02/19, Down 2%) It is a good place to remain. It is diversified in several medical services. He still holds it.
DON'T BUY

60 names, equally weighted. Prefers names like JNJ, Bristol Myers, UNH, or Merck. His ETF strategy is VHT in US dollars, with more exposure to larger names. Healthcare will be choppy, but it's cheap. Demographics are in its favour.

TOP PICK
It has been beaten up a little because of Big Pharma overcharging and so for but the demographics don't change. It is time to go. A timely hold.
COMMENT
A laggard. Only 10% is in the managed care. Like clock word every election period, these stocks go under a lot of pressure. He mentions an article from the WSJ thus weekend that suggest that the sector has gone through enough of a correction that now it shows good value. Doesn't have enough yield.
Showing 1 to 15 of 44 entries

BMO EqWt US HthCare Hedged CAD (ZUH.TO) Frequently Asked Questions

What is BMO EqWt US HthCare Hedged CAD stock symbol?

BMO EqWt US HthCare Hedged CAD is a Canadian stock, trading under the symbol ZUH.TO (previously ZUH-T on Stockchase) on the Toronto Stock Exchange (ZUH-CT). It is usually referred to as TSX:ZUH or ZUH.TO

Is BMO EqWt US HthCare Hedged CAD a buy or a sell?

In the last year, 1 stock analyst published opinions about ZUH.TO (previously ZUH-T on Stockchase). 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for BMO EqWt US HthCare Hedged CAD.

Is BMO EqWt US HthCare Hedged CAD a good investment or a top pick?

BMO EqWt US HthCare Hedged CAD was recommended as a Top Pick by Mike S. Newton, CIM FCSI on 2019-04-24. Read the latest stock experts ratings for BMO EqWt US HthCare Hedged CAD.

Why is BMO EqWt US HthCare Hedged CAD stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.

Is BMO EqWt US HthCare Hedged CAD worth watching?

1 stock analyst on Stockchase covered BMO EqWt US HthCare Hedged CAD in the last year. It is a trending stock that is worth watching.

What is BMO EqWt US HthCare Hedged CAD stock price?

On 2026-06-11, BMO EqWt US HthCare Hedged CAD (ZUH.TO) stock closed at a price of $68.82.